e-learning
resources
Munich 2006
Sunday 03.09.2006
Tuberculosis and other pulmonary infections
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Features of community acquired pneumonia in patients hospitalized in the institute for pulmonary diseases over a five-year period
M. D. Djuric, D. Povazan, N. G. Secen, V. Kosjerina (Sremska Kamenica, Serbia And Montenegro)
Source:
Annual Congress 2006 - Tuberculosis and other pulmonary infections
Session:
Tuberculosis and other pulmonary infections
Session type:
Electronic Poster Discussion
Number:
1023
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. D. Djuric, D. Povazan, N. G. Secen, V. Kosjerina (Sremska Kamenica, Serbia And Montenegro). Features of community acquired pneumonia in patients hospitalized in the institute for pulmonary diseases over a five-year period. Eur Respir J 2006; 28: Suppl. 50, 1023
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Mortality in patients with COPD due to community acquired pneumonia
Source: Annual Congress 2007 - Severity scores and comorbidities in community-acquired pneumonia
Year: 2007
Comparison of prospective scores for predicting mortality and hospital admission in hospitalised patients and out-patients with CAP
Source: Annual Congress 2005 - Community-acquired pneumonia: clinical approaches
Year: 2005
Clinical features associated with mortality in patients with community acquired pneumonia requiring hospitalisation
Source: Eur Respir J 2004; 24: Suppl. 48, 414s
Year: 2004
Frequency of cardiovascular events in hospitalised patients with community acquired pneumonia
Source: Annual Congress 2009 - Complications of respiratory infections: impact of comorbidities and infections caused by Aspergillus
Year: 2009
Pathological investigations of cardiovascular system in patients who died from community acquired pneumonia
Source: Eur Respir J 2001; 18: Suppl. 33, 465s
Year: 2001
Chronic pulmonary aspergillosis in France: prevalence, associated chronic pulmonary diseases and prognosis in a 10-year retrospective study of the French nationwide administrative hospital database.
Source: International Congress 2019 – Clinical challenges in respiratory infection
Year: 2019
A prospective comparison of nursing home acquired pneumonia with community acquired pneumonia
Source: Eur Respir J 2001; 18: 362-368
Year: 2001
Cardiac diseases in patients with community acquired pneumonia (CAP)
Source: Annual Congress 2012 - Epidemiology: risk factors and prognosis in respiratory infections
Year: 2012
The general evaluation of community acquired pneumonia patients treated in our clinic
Source: Eur Respir J 2004; 24: Suppl. 48, 414s
Year: 2004
Management of hospital admitted community acquired pneumonia cases in the hospital for diseases of the chest in Athens
Source: Eur Respir J 2002; 20: Suppl. 38, 357s
Year: 2002
Ocular manifestations in unselected group of sarcoid patients hospitalised in the national tuberculosis and lung diseases research institute
Source: Eur Respir J 2002; 20: Suppl. 38, 435s
Year: 2002
The general evaluation of elderly patients with community acquired pneumonia
Source: Eur Respir J 2004; 24: Suppl. 48, 412s
Year: 2004
The incidence of Q fever in hospitalized patients with community acquired pneumonia
Source: Annual Congress 2008 - Diagnostic tests in lower respiratory tract infections
Year: 2008
Determinants of vaccination in patients with community acquired pneumonia (CAP) or chronic lung diseases
Source: Annual Congress 2004 - Community acquired pneumonia - epidemiology and host defence
Year: 2004
Antibiotic prescription patterns in hospitalized patients with community-acquired pneumonia in local hospital: 10 year follow-up
Source: Annual Congress 2011 - Antimicrobial treatment and resistance in lower respiratory tract infections
Year: 2011
The relevance of chronic obstructive pulmonary disease on mortality in patients with community acquired pneumonia
Source: Annual Congress 2010 - Colonisation and infection in COPD
Year: 2010
AUDIPOC. National clinical audit on chronic obstructive pulmonary disease exacerbations (eEPOC) in Spain. Mortality and readmission at 90 days of patients admitted for eEPOC. Influence of hospitalization department
Source: Annual Congress 2009 - Healthcare and treatment of COPD
Year: 2009
Risk factors of treatment failure of community acquired pneumonia in patients with COPD
Source: Annual Congress 2008 - Treatment and outcome in hospitalised patients with community-acquired pneumonia
Year: 2008
Consequences of community acquired pneumonia requiring admission to hospital in childhood
Source: Eur Respir J 2004; 24: Suppl. 48, 171s
Year: 2004
Factors associated with one-year mortality in hospitalized patients with exacerbation of bronchiectasis.
Source: Virtual Congress 2020 – New investigations of bronchiectasis and non-tuberculous mycobacteria
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept